Search

Author/Creator Enweonye, Igwebuike

1. Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial' [Vaccine 36 (2018) 4278–4286]. Issue 9 (21st February 2019)

Authors:
Maréchal, Céline; Lal, Himal; Poder, Airi; Ferguson, Murdo; Enweonye, Igwebuike; Heineman, Thomas C.; Hervé, Caroline; Rheault, Paul; Talli, Jaak; Wauters, Dominique; Oostvogels, Lidia
Journal:
Vaccine
Issue:
Volume 37:Issue 9(2019)
Page Start:
1252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial. Issue 29 (5th July 2018)

Authors:
Maréchal, Céline; Lal, Himal; Poder, Airi; Ferguson, Murdo; Enweonye, Igwebuike; Heineman, Thomas C; Hervé, Caroline; Rheault, Paul; Talli, Jaak; Wauters, Dominique; Oostvogels, Lidia
Journal:
Vaccine
Issue:
Volume 36:Issue 29(2018)
Page Start:
4278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications. (August 2016)

Authors:
Diez-Domingo, Javier; de Martino, Maurizio; Lopez, Jose Garcia-Sicilia; Zuccotti, Gian Vincenzo; Icardi, Giancarlo; Villani, Alberto; Moreno-Perez, David; Hernández, María Méndez; Aldeán, Javier Álvarez; Mateen, Ahmed Abdul; Enweonye, Igwebuike; de Rooij, Richard; Chandra, Richa
Journal:
International journal of infectious diseases
Issue:
Volume 49(2016:Aug.)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications. (August 2016)

Authors:
Diez-Domingo, Javier; de Martino, Maurizio; Lopez, Jose Garcia-Sicilia; Zuccotti, Gian Vincenzo; Icardi, Giancarlo; Villani, Alberto; Moreno-Perez, David; Hernández, María Méndez; Aldeán, Javier Álvarez; Mateen, Ahmed Abdul; Enweonye, Igwebuike; de Rooij, Richard; Chandra, Richa
Journal:
International journal of infectious diseases
Issue:
Volume 49(2016:Aug.)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial. Issue 39 (16th September 2019)

Authors:
Strezova, Ana; Lal, Himal; Enweonye, Igwebuike; Campora, Laura; Beukelaers, Pierre; Segall, Nathan; Heineman, Thomas C.; Schuind, Anne E.; Oostvogels, Lidia
Journal:
Vaccine
Issue:
Volume 37:Issue 39(2019)
Page Start:
5877
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗